Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Furiex Pharmaceuticals, Inc. (FURX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08
   10-K10-K10-K10-K10-K10-K
Revenue:        
Milestones  45.020.0 7.5  
Royalties  26.020.54.51.30.9 
    Total revenue  71.040.54.59.06.318.4
            Total revenue growth  75.3%802.2%-50.0%42.3%-65.7% 
Research and development expenses  82.769.544.250.111.8 
Selling, general and administrative expenses  12.711.38.88.32.6 
Depreciation and amortization  0.10.10.10.10.0 
    Total operating expenses  95.480.953.0141.514.6 
    Operating income (loss)  -24.4-40.3-48.6-49.5-8.3 
            Operating margin  -34.4%-99.6%-1081.4%-551.3%-131.6% 
Interest expense  5.02.50.4   
Other income, net  0.10.00.00.00.0 
    Income (loss) before provision for income taxes  -29.3-42.9-49.0-49.5-8.36.8
Less provision for income taxes  0.30.00.00.00.6 
            Tax rate       0.0%
    Net income (loss)  -29.7-42.9-49.0-54.7-8.9 
   
Net income (loss) per basic share (in Dollars per share)  ($2.92)($4.29)($4.96)($5.53)($0.90) 
Net income (loss) per diluted share (in Dollars per share)  ($2.92)($4.29)($4.96)($5.53)($0.90) 
   
Weighted-average shares used to compute net income  10.110.09.99.9  
    Weighted-average shares used to compute net income  10.110.09.9   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy